Pharmacy News
Superdrug ‘first to stock’ £99 non-hormonal menopause medication
In Pharmacy News
Stay up to date with all the news, learning and insight in the world of pharmacy.Bookmark
Record learning outcomes
Superdrug has said it is the first high street business in the UK to stock Veoza, a non-hormonal medicine aimed at alleviating the symptoms of menopause.
The product, which contains fezolinetant 45mg and targets hot flushes and night sweats, will retail at £99 for a pack of 28, the company said.
The drug is indicated for perimenopausal, menopausal and postmenopausal women aged 45-65 who are not on HRT or hormonal contraception and are suffering from moderate to severe vasomotor symptoms, said Superdrug.
Dr Babak Ashrafi, a GP working for Superdrug Online Doctor, commented: “As a healthcare provider, I am impressed by the positive outcomes observed with Veoza.
“According to the Lancet study, compared with the placebo, fezolinetant 45mg significantly reduced the frequency and severity of vasomotor symptoms at week 4 and week 12. Improvements in frequency and severity of vasomotor symptoms were observed after one week and maintained over two weeks.”
Superdrug healthcare director Ghada Beale said: “We understand the unique challenges faced during menopause and are dedicated to offering accessible, effective and choice-driven solutions.”